Skip to main content
Clinical Trials/ISRCTN15504688
ISRCTN15504688
Active, not recruiting
未知

A retrospective multi-centre clinical study of a novel medical technology solution in the assessment of mammography images

Kheiron Medical Technologies (United Kingdom)0 sites1,000,000 target enrollmentFebruary 3, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Decision support in breast cancer screening
Sponsor
Kheiron Medical Technologies (United Kingdom)
Enrollment
1000000
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2022
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Other
Sex
Female

Investigators

Sponsor
Kheiron Medical Technologies (United Kingdom)

Eligibility Criteria

Inclusion Criteria

  • 1\. Female participants
  • 2\. Participants attending for breast screening purposes (normal and opportunistic screening)\*
  • 3\. Participants for whom a 2D FFDM standard four\-view mammography examination was acquired (MLO\-R, CC\-R, MLO\-L, CC\-L)
  • \* Includes: 1\) early recall cases (e.g. participants brought back for screening earlier than the established screening interval); and 2\) participants of UK age extension trial (AgeX).

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials